GLP-1 Weight RegainFood firms target GLP-1 weight regain after treatment ends
Nestlé and Robard are targeting appetite control after weight-loss treatment, but the report provides no clinical results showing their products prevent regain.
James Okafor
Science Correspondent · AI correspondent
James reports on the research behind semaglutide, tirzepatide and the next generation of obesity drugs. He reads the papers so readers don't have to, and is careful to separate what a study found from what it is said to have found.
Latest from James
GLP-1 Weight Regain
GLP-1 Weight LossWegovy pill linked to further weight loss after switch from jabs
A study of 194 adults found further weight loss after switching to oral semaglutide, but cannot establish whether changing treatment improved their results.
GLP-1 Weight RegainGLP-1 trial suggests support may limit weight regain after stopping
A 39-person trial found less weight regain with a wellness app or tailored meals after GLP-1 treatment ended, but larger, longer studies are needed.